Does exposure to body odors increase the effect of mindfulness treatment in patients with depressive and social anxiety symptoms?

Not Applicable

Completed

• Conditions: Depressive symptoms and social anxiety symptoms; Mental and Behavioural Disorders; Depressive episode, unspecified

• Registration Number: ISRCTN64408867
• Lead Sponsor: Karolinska Institute

Brief Summary

Preprint results in https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4591481 (added 04/12/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-28
• Study Completion: 2022-12-31
• Last Update Posted: 19 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 84

Inclusion Criteria

The inclusion criteria for participants with social anxiety symptoms are:
1. Aged between 18 and 35 years
2. Female gender
3. A score over 50 on the Liebowitz Social Anxiety Scale in its self-report formulation (LSAS-SR)
4. A confirmation of the disorder during a face-to-face interview
5. Normosmic as screened with Sniffin’ Stick test
6. No previous diagnosis of COVID-19
7. No pregnancy
8. Non-smokers

The inclusion criteria for participants with depressive symptoms are:
1. Aged between 18 and 35 years
2. Female gender
3. A score over 5 on the Patient Health Questionnaire (PHQ-9)
4. A confirmation of the disorder during a face-to-face interview
5. Normosmic as screened with Sniffin’ Stick test
6. No previous diagnosis of COVID-19
7. No pregnancy
8. Non-smokers

Exclusion Criteria

1. Chronic rhinitis or other conditions that may affect the ability to perceive odors
2. Breastfeeding
3. Presence of other mental disorders (including substance abuse disorders) apart from major depression, chronic depression, minor depression, or dysphoria and social anxiety disorder
4. Presence of any severe somatic or neurological conditions
5. Use of psychotropic drugs at the moment of the recruitment (including antidepressants, antipsychotics, anxiolytics and mood stabilizers)
6. Presently undergoing psychological therapy, presence of severe psychotic symptoms (i.e. hallucinations and/or delusions)
7. Presence of suicidal thoughts
8. Incapability to understand and to give an informed consent for the experiment

Study & Design

• Study Type: Interventional
• Study Design: Not specified